WCLC 2025 - Posters & ePosters-P3.12.66 Overcoming Osimertinib Resistance in EGFR<+ NSCLC: PI3K Inhibitor Combined With Osimertinib Restores Drug Sensitivity

P3.12.66 Overcoming Osimertinib Resistance in EGFR<+ NSCLC: PI3K Inhibitor Combined With Osimertinib Restores Drug Sensitivity

Asset Subtitle

Lin Jiang

Meta Tag

Speaker Lin Jiang

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy